Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | AHR | HBM |
|---|---|---|
| Price | $50.69 | $26.32 |
| Change today | ▼ 1.12% | ▼ 1.35% |
| Market cap | $11.72B | $11.69B |
| Return, 3 months | – | – |
| Return, year to date | – | – |
| Return, 1 year | – | – |
| P/E (TTM) | 74.5 | 16.2 |
| P/B | 3.2 | 3.3 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.97% | 0.08% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +25.1% | +21.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | – | – |
| 30-day volatility | – | – |
| Max drawdown, 1 year | – | – |
| Trend read | – | – |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
